- Home
- / CMG Pharmaceutical
CMG Pharmaceutical
Revenue
₩105.2 B
FY, 2025
CMG Pharmaceutical Summary
Company Summary
- Overview
- CMG Pharmaceutical is a company that specializes in the oral thin film (OTF) technology. OTF is based on water-soluble polymers and is designed to be melted in mouth without water. The company provides a range of products to treat erectile dysfunction, hepatitis type B, schizophrenia, and asthma.
- Type
- Public
- Status
- Active
- Founded
- 2001
- HQ
- Seongnam-si, KR | view all locations
- Website
- http://cmgpharma.co.kr/
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
1 location detected
Seongnam-si, Gyeonggi-do HQ
Korea (Republic of)
Pangyo-ro, Bundang-gu
CMG Pharmaceutical Financials
Summary Financials
- Revenue (FY, 2025)
- ₩105.2B
- Gross profit (FY, 2025)
- ₩61.8B
- Net income (FY, 2025)
- (₩10.1B)
- Cash (FY, 2025)
- ₩6.1B
- EBIT (FY, 2025)
- (₩10.7B)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026